Online Program Home
My Program

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

303 * Tue, 7/31/2018, 8:30 AM - 10:20 AM CC-West 115
Patient-Centered Outcomes, Patient Preferences, and Patient Reports — Contributed Papers
Health Policy Statistics Section
Chair(s): David Michael Vock, University of Minnesota
8:35 AM Personalization Through Uplift Modeling: Techniques and Business Applications
Victor Lo, Fidelity Investments
8:50 AM A Comprehensive Germ Cell Tumor Data Commons and Its Application in Risk Classification Model Validation

Bo Ci; Yang Xie, University of Texas Southwestern Medical Center ; Lindsay Frazier, Dana-Farber Cancer Institute; Matthew Murray, Cambridge University Hospitals; James Amatruda, University of Texas Southwestern Medical Center; Mark Krailo, University of Southern California; Samuel Volchenboum, University of Chicago; Bo Yao, University of Texas Southwestern Medical Center; Caihong Xia, Children's Oncology Group; Lin Xu, University of Texas Southwestern Medical Center; Danni Luo, University of Texas Southwestern Medical Center; Shin-Yi Lin, University of Texas Southwestern Medical Center
9:05 AM Experimental Design Issues in Choice Based Conjoint Applied to Patient Choice in Healthcare

Pallavi Chitturi, Temple University; Alexandra Carides, Temple University
9:20 AM Patient Satisfaction with Health Care and Its Association with Health Care Utilization Among Patients with Rheumatoid Arthritis (RA)

Chenghui Li; Nasim A Khan, University of Arkansas for Medical Sciences
9:35 AM How Much Is Too Much: Impact of Missing Data Rates in Patient Reported Outcomes Research
Katie L Kunze, Mayo Clinic; Paul J. Novotny, Mayo Clinic; Jeff A. Sloan, Mayo Clinic; Blake T. Langlais, Mayo Clinic; Amylou C. Dueck, Mayo Clinic
9:50 AM The Center for Biologics (CBER) Experience with Patient-Reported Outcomes (PROs) in Rare Diseases
Hussein Ezzeldin, The U.S. Food and Drug Administration; Megan Moncur, The U.S. Food and Drug Administration; Yuqun Abigail Luo, The U.S. Food and Drug Administration; Telba Irony, The U.S. Food and Drug Administration
10:05 AM Floor Discussion